Therapy Insight: Fertility in women after cancer treatment

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 12, 2007, Pages 819-826

  Morice, Philippe ^a,c   Pautier, Patricia ^a   Fanchin, Renato ^b,c   Haie Meder, Christine ^a   Chauveaud Lambling, Aurelia ^b   Frydman, René ^b,c   Frydman, Nelly ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cancer treatment; Chemotherapy; Conservative surgery; Fertility; Radiation therapy

Indexed keywords

ANUS CANCER; BRACHYTHERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHILDHOOD CANCER; CRYOPRESERVATION; CYTOTOXICITY; DISEASE MARKER; ECHOGRAPHY; ENDOMETRIUM CANCER; EPENDYMOMA; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; GONAD; HUMAN; HYSTERECTOMY; OOCYTE; OVARIECTOMY; OVARY; OVARY CANCER; OVARY FUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; UTERINE CERVIX CANCER; UTERUS FUNCTION; UTERUS TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FERTILITY; HUMANS; NEOPLASMS; OVARY; RADIOTHERAPY;

EID: 36349013097     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0675     Document Type: Review

References (65)

1. Jemal A et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130
2. Lee SJ et al. (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24: 2917-2931
3. Shimada M et al. (2006) Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol 101: 234-237
4. Creasman WT et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60: 2035-2041
5. Benjamin I et al. (1999) Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 72: 288-291
6. Critchley HO and Wallace WH (2005) Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 34: 64-68
7. Meirow D and Nugent D (2001) The effect of radiotherapy and chemotherapy on female reproduction. Human Reprod Update 7: 535-543
8. Chiarelli AM et al. (1999) Early menopause and infertility in females after treatment of childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 150: 245-254
9. Larsen EC et al. (2003) Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88: 5307-5314
10. Bath LE et al. (2003) Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 18: 2368-2374
11. Sklar CA et al. (2006) Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Nat Clin Invest 98: 890-896
12. Jones AL (2006) Fertility and pregnancy after breast cancer. Breast 15 (Suppl 2): S41-S46
13. Elis A et al. (2006) Fertility status among women treated for aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 47: 623-627
14. Franchi-Rezgui P et al. (2003) Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 4: 116-120
15. Faddy MJ et al. (1992) Accelerated disappearance of ovarian follicles in the mid-life: implications for forecasting menopause. Hum Reprod 7: 1342-1346
16. Haie-Meder C et al. (1993) Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiol Oncol Biol Physics 25: 419-424
17. Bath LE et al. (1999) Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Brit J Obstet Gynaecol 106: 1265-1272
18. Holm K et al. (1999) Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogenic bone marrow transplantation. Bone Marrow Transplant 23: 359-363
19. Corson SL et al. (1999) Inhibin-B as a test of ovarian reserve for infertile women. Hum Reprod 14: 2818-2821
20. Hall JE et al. (1999) Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14: 409-415
21. Creus M et al. (2000) Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod 15: 2341-2346
22. Bancsi LF et al. (2000) Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 73: 552-557
23. Vigier B et al. (1984) Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114: 1315-1320
24. Eldar-Geva T et al. (2005) Dynamic assays of inhibin B, anti-Müllerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 20: 3178-3183
25. Baarends WM et al. (1995) Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136: 4951-4962
26. Durlinger AL et al. (2002) Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 124: 601-609
27. Weenen C et al. (2004) Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10: 77-83
28. De Vet A et al. (2002) Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77: 357-362
29. Fanchin R et al. (2003) Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18: 323-327
30. Fanchin R et al. (2005) High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20: 923-927
31. Gougeon A (1996) Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 17: 121-155
32. Haie-Meder C et al. (2004) Consequences of brachytherapy on uterine myocontractility. Radiother Oncol Suppl 71: S54
33. Morice P et al. (2000) Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril 74: 743-748
34. Yamamoto R et al. (2001) A study of risk factor for ovarian metastases in stage IB-IIB cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol 82: 312-316
35. Morice P et al. (2006) Borderline tumor of the ovary and fertility. Eur J Cancer 42: 149-158
36. Basille C et al. (2006) Impact of gonadotropins and steroid hormons on borderline ovarian cells. Hum Reprod 21: 3241-3245
37. Fortin N et al. (2007) Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study. Fertil Steril 87: 591-596
38. Chopin N et al. (2006) Radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy: an international series. Int J Gynecol Cancer 16 (Suppl 3): 602
39. Morice P et al. (2005) Conservative treatment of epithelial ovarian cancer: results of a French multicenter study of the GCCLCC (Groupe des Chirurgiens de Centres de Lutte Contre le Cancer) and SFOG (Societe Française d'Oncologie Gynécologique). Hum Reprod 20: 1379-1385
40. Roberts JE and Oktay K (2005) Fertility preservation: a comprehensive approach to the young woman with cancer. J Natl Cancer Inst Monogr 34: 57-59
41. Blumenfeld Z and Eckman A (2005) Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. J Natl Cancer Inst Monogr 34: 40-43
42. Ataya K et al. (1995) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52: 365-372
43. Pereyra Pacheco B et al. (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81: 391-397
44. Lobo R (2005) Potential options for preservation of fertility in women. N Engl J Med 353: 64-73
45. Oktay K et al. (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91: 3885-3890
46. Trounson A and Mohr L (1983) Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 305: 707-709
47. Lassalle B et al. (1985) Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol. Fertil Steril 44: 645-651
48. Cohen J et al. (1985) Pregnancies following the frozen storage of expanding human blastocysts. J In Vitro Fert Embryo Transf 2: 59-64
49. Mukaida T et al. (2003) Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos. Hum Reprod 13: 2874-2879
50. Mukaida T et al. (2003) Vitrification of human blastocysts using cryoloops: clinical outcome of 223 cycles. Hum Reprod 18: 384-391
51. Vanderzwalmen P et al. (2003) Vitrification of human blastocysts with the Hemi-Straw carrier: application of assisted hatching after thawing. Hum Reprod 18: 1504-1511
52. Stehlik E et al. (2005) Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online 11: 53-57
53. Chen SU et al. (2005) Observational clinical follow-up of oocyte cryopreservation using a slow-freezing method with 1,2-propanediol plus sucrose followed with ICSI. Hum Reprod 20: 1975-1980
54. Porcu E et al. (1997) Birth of a six healthy children after intracytoplasmic sperm injection of cryopreserved human oocytes. Hum Reprod 68: 724-726
55. Porcu E et al. (2000) Clinical experience and applications of oocyte cryopreservation. Mol Cell Endocrinol 169: 33-37
56. Kuleshova L et al. (1999) Birth following vitrification of a small number of human oocytes: case report. Hum Reprod 14: 3077-3079
57. Yoon TK et al. (2000) Pregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril 74: 180-181
58. Yoon TK et al. (2003) Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril 79: 1323-1326
59. Katayama KP et al. (2003) High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 80: 223-224
60. Antinori M et al. (2007) Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod BioMed Online 14: 72-79
61. Barritt J et al. (2007) Report of four donor-recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil Steril 87: 189-197
62. Callejo J et al. (2001) Long-term ovarian function evaluation after autografting by transplantation with fresh and frozen-thawed human ovarian tissue. J Clin Endocrinol Metab 86: 4489-4494
63. Oktay K et al. (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363: 837-840
64. Donnez J et al. (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364: 1405-1410
65. Meirow D et al. (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353: 318-321